rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2005-4-22
|
pubmed:abstractText |
The primary challenge for tissue engineering is to develop a vascular supply that can support the metabolic needs of the engineered tissues in an extracellular matrix. In this study, the feasibility of using a natural compound, ginsenoside Re, isolated from Panax ginseng in stimulating angiogenesis and for tissue regeneration was evaluated.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0724-8741
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
636-46
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15846472-Angiogenesis Inducing Agents,
pubmed-meshheading:15846472-Animals,
pubmed-meshheading:15846472-Cattle,
pubmed-meshheading:15846472-Cell Line,
pubmed-meshheading:15846472-Cell Movement,
pubmed-meshheading:15846472-Cell Proliferation,
pubmed-meshheading:15846472-Extracellular Matrix,
pubmed-meshheading:15846472-Fibroblast Growth Factor 2,
pubmed-meshheading:15846472-Fixatives,
pubmed-meshheading:15846472-Ginsenosides,
pubmed-meshheading:15846472-Humans,
pubmed-meshheading:15846472-Iridoid Glycosides,
pubmed-meshheading:15846472-Iridoids,
pubmed-meshheading:15846472-Male,
pubmed-meshheading:15846472-Panax,
pubmed-meshheading:15846472-Pericardium,
pubmed-meshheading:15846472-Pyrans,
pubmed-meshheading:15846472-Rats,
pubmed-meshheading:15846472-Rats, Wistar,
pubmed-meshheading:15846472-Staining and Labeling,
pubmed-meshheading:15846472-Tissue Engineering
|
pubmed:year |
2005
|
pubmed:articleTitle |
A natural compound (ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration.
|
pubmed:affiliation |
Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan, Republic of China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|